Real-world evidence on fremanezumab for migraine treatment in Japan: a retrospective analysis

被引：0
|
作者：
Takizawa, T. [1 ]
Ohtani, S. [1 ,2 ]
Watanabe, N. [1 ]
Ihara, K. [1 ]
Takahashi, N. [1 ]
Miyazaki, N. [3 ]
Ishizuchi, K. [1 ]
Takemura, R. [3 ]
Hori, S. [2 ]
Nakahara, J. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan
[2] Keio Univ, Fac Pharm, Div Drug Informat, Tokyo, Japan
[3] Keio Univ Hosp, Biostat Unit, Clin & Translat Res Ctr, Tokyo, Japan
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P254
引用
收藏
页数：1
相关论文
共 50 条
  • [31] REDUCTIONS IN MIGRAINE AND HEADACHE DAYS WITH QUARTERLY AND MONTHLY FREMANEZUMAB IN ADULT PATIENTS WITH MIGRAINE IN A US REAL-WORLD SETTING
    Cohen, J.
    Thompson, S.
    Ayyagari, R.
    Driessen, M.
    Seminerio, M.
    Carr, K.
    Yim, E.
    VALUE IN HEALTH, 2022, 25 (01) : S36 - S36
  • [32] Real-world evidence of the effectiveness and satisfaction with eptinezumab treatment in patients with chronic migraine
    Argoff, C.
    Khan, F.
    Herzog, S.
    Smith, R.
    Kotak, S.
    Sopina, L.
    Soni-Brahmbhatt, S.
    Kymes, S.
    HEADACHE, 2023, 63 : 160 - 161
  • [33] Impact of Fremanezumab Treatment on Clinical Outcomes Among Migraine Patients With Comorbid Depression, Anxiety or Hypertension in a Real-World Setting
    Tangirala, K.
    Pedarla, V.
    Driessen, M.
    Krasenbaum, L. J.
    Thompson, S. F.
    Maughn, K.
    Seminerio, M. J.
    Cohen, J. M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 114 - 114
  • [34] Impact of Fremanezumab Treatment on Clinical Outcomes Among Migraine Patients With Comorbid Depression, Anxiety or Hypertension in a Real-World Setting
    Tangirala, K.
    Pedarla, V.
    Driessen, M.
    Krasenbaum, L. J.
    Thompson, S. F.
    Maughn, K.
    Seminerio, M. J.
    Cohen, J. M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 169 - 169
  • [35] A real-world analysis of outcomes in migraneurs receiving preventive migraine treatment
    Ford, J. H.
    Jackson, J.
    Milligan, G.
    Cotton, S.
    Ahl, J.
    HEADACHE, 2016, 56 : 66 - 66
  • [36] Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan
    Tanaka, Yoshiya
    Nakayamada, Shingo
    Yamaoka, Kunihiro
    Ohmura, Koichiro
    Yasuda, Shinsuke
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 145 - 153
  • [37] A Real-world analysis of the burden of migraine in patients with prior treatment failure: evidence from the BECOME study
    Lucas, C.
    Pozo-Rosich, P.
    Watson, D.
    Gaul, C.
    Ramsden, E.
    Ritter, S.
    Martelletti, P.
    Snellman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 801 - 801
  • [38] A real-world analysis of the burden of migraine in patients with prior treatment failures: evidence from the BECOME study
    Lucas, Christian
    Pozo-Rosich, Patricia
    Watson, David
    Gaul, Charly
    Ramsden, Emma
    Ritter, Shannon
    Martelletti, Paolo
    Snellman, Josefin
    JOURNAL OF HEADACHE AND PAIN, 2019, 20
  • [39] A Real-World Analysis of the Burden of Migraine in Patients with Prior Treatment Failure: Evidence from the BECOME Study
    Lucas, Christian
    Pozo-Rosich, Patricia
    Watson, David P. B.
    Gaul, Charly
    Ramsden, Emma
    Ritter, Shannon
    Martelletti, Paolo
    Snellman, Josefin
    CEPHALALGIA, 2019, 39 : 111 - 112
  • [40] A Real-World Analysis of the Burden of Migraine in Patients with Prior Treatment Failure: Evidence from the BECOME Study
    Lucas, C.
    Pozo-Rosich, P.
    Watson, D.
    Gaul, C.
    Ramsden, E.
    Ritter, S.
    Martelletti, P.
    Snellman, J.
    HEADACHE, 2019, 59 : 60 - 62
12345